Back

REDWOOD-HCM OLE: aficamten in HCM

23 May 2022 (17:10 - 17:20)
Organised by:
Congress Presentation Part of: Registries and Trial updates II Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Ahmad Masri

Oregon Health & Science University Medical Group, Portland (United States of America)

3 More presentations in this session

Presentation thumbnail
The CLOROTIC trial: Combination of Loop Diuretics with Hydrochlorothiazide in Acute Heart Failure
Doctor J. Trullas (Olot, ES)
Slides Video
Presentation thumbnail
EMPEROR-Preserved: Outcomes using alternate endpoint definitions
Professor J. Butler (Dallas, US)
Slides Video
Presentation thumbnail
GALACTIC-HF and tricuspid regurgitation
Associate Professor M. Adamo (Brescia, IT)
Slides Video

Access the full session

Session thumbnail
Registries and Trial updates II
Video

The Event

Event poster

Heart Failure 2022

23 May 2022 17:10 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms
thumbnail
Congress Presentation
Aficamten for the treatment of symptomatic obstructive hypertrophic cardiomyopathy: SEQUOIA-HCM an international multicenter phase 3 trial
thumbnail
Congress Presentation
Efficacy and safety of long-term treatment with aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy: results from FOREST-HCM

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources